Metastatic progression of prostate cancer and E-cadherin: Regulation by ZEB1 and Src family kinases

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 400-410

  Putzke, Aaron P ^a,c   Ventura, Aviva P ^a   Bailey, Alexander M ^a   Akture, Canan ^a   Opoku Ansah, John ^a   Çeliktaş, Müge ^a   Hwang, Michael S ^a   Darling, Douglas S ^d   Coleman, Ilsa M ^b   Nelson, Peter S ^b   Nguyen, Holly M ^e   Corey, Eva ^e   Tewari, Muneesh ^b   Morrissey, Colm ^e   Vessella, Robert L ^e   Knudsen, Beatrice S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c HOPE COLLEGE   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; MATRIGEL; PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN ZEB1; RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER GROWTH; CELL CULTURE; CELL MIGRATION; CELL STRAIN; CELL STRAIN DU145; CELL STRUCTURE; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MESENCHYME CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SOFT TISSUE METASTASIS; TIBIA;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TIBIA; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS;

EID: 80052475968     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.028     Document Type: Article

References (60)

1. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol 17 2005 548 558
2. M. Zeisberg, and R. Kalluri The role of epithelial-to-mesenchymal transition in renal fibrosis J Mol Med 82 2004 175 181
3. J.M. Halbleib, and W.J. Nelson Cadherins in development: cell adhesion, sorting, and tissue morphogenesis Genes Dev 20 2006 3199 3214
4. U. Cavallaro, and G. Christofori Multitasking in tumor progression: signaling functions of cell adhesion molecules Ann NY Acad Sci 1014 2004 58 66
5. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7 2007 415 428
6. H. Acloque, M.S. Adams, K. Fishwick, M. Bronner-Fraser, and M.A. Nieto Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease J Clin Invest 119 2009 1438 1449
7. J.M. Drake, G. Strohbehn, T.B. Bair, J.G. Moreland, and M.D. Henry ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells Mol Biol Cell 20 2009 2207 2217
8. T.R. Graham, H.E. Zhau, V.A. Odero-Marah, A.O. Osunkoya, K.S. Kimbro, M. Tighiouart, T. Liu, J.W. Simons, and R.M. O'Regan Insulin-like growth factor-Idependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells Cancer Res 68 2008 2479 2488
9. T.J. Harris, and U. Tepass Adherens junctions: from molecules to morphogenesis Nat Rev Mol Cell Biol 11 2010 502 514
10. K. Giehl, and A. Menke Microenvironmental regulation of E-cadherinmediated adherens junctions Front Biosci 13 2008 3975 3985
11. A.B. Reynolds, and R.H. Carnahan Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer Semin Cell Dev Biol 15 2004 657 663
12. S.K. Kachhap, D. Faith, D.Z. Qian, S. Shabbeer, N.L. Galloway, R. Pili, S.R. Denmeade, A.M. DeMarzo, and M.A. Carducci The N-Myc down regulated gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin PLoS ONE 2 2007 e844
13. D. Kong, S. Banerjee, A. Ahmad, Y. Li, Z. Wang, S. Sethi, and F.H. Sarkar Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells PLoS One 5 2010 e12445
14. E. Giannoni, F. Bianchini, L. Masieri, S. Serni, E. Torre, L. Calorini, and P. Chiarugi Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness Cancer Res 70 2010 6945 6956
15. P. Mak, I. Leav, B. Pursell, D. Bae, X. Yang, C.A. Taglienti, L.M. Gouvin, V.M. Sharma, and A.M. Mercurio ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated SNAIL nuclear localization: implications for Gleason grading Cancer Cell 17 2010 319 332
16. D. Xie, C. Gore, J. Liu, R.C. Pong, R. Mason, G. Hao, M. Long, W. Kabbani, L. Yu, H. Zhang, H. Chen, X. Sun, D.A. Boothman, W. Min, and J.T. Hsieh Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis Proc Natl Acad Sci USA 107 2010 2485 2490
17. L. Cheng, M. Nagabhushan, T.P. Pretlow, S.B. Amini, and T.G. Pretlow Expression of E-cadherin in primary and metastatic prostate cancer Am J Pathol 148 1996 1375 1380
18. R. Umbas, W.B. Isaacs, P.P. Bringuier, Y. Xue, F.M. Debruyne, and J.A. Schalken Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer Int J Cancer 74 1997 374 377
19. M. Kuczyk, J. Serth, S. Machtens, C. Bokemeyer, W. Bathke, C. Stief, and U. Jonas Expression of E-cadherin in primary prostate cancer: correlation with clinical features Br J Urol 81 1998 406 412
20. A.M. De Marzo, B. Knudsen, K. Chan-Tack, and J.I. Epstein E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens Urology 53 1999 707 713
21. B.V. Kallakury, C.E. Sheehan, and J.S. Ross Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas Hum Pathol 32 2001 849 855
22. Q. Lu, L.J. Dobbs, C.W. Gregory, G.W. Lanford, M.P. Revelo, S. Shappell, and Y.H. Chen Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer Hum Pathol 36 2005 1037 1048
23. D.S. Rao, D. Gui, M.E. Koski, L.M. Popoviciu, H. Wang, R.E. Reiter, and J.W. Said An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer Appl Immunohistochem Mol Morphol 14 2006 375 383
24. H.F. Yuen, C.W. Chua, Y.P. Chan, Y.C. Wong, X. Wang, and K.W. Chan Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer Histopathology 50 2007 648 658
25. I.M. van Oort, K. Tomita, A. van Bokhoven, M.J. Bussemakers, L.A. Kiemeney, H.F. Karthaus, J.A. Witjes, and J.A. Schalken The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study Prostate 67 2007 1432 1438
26. K. Gravdal, O.J. Halvorsen, S.A. Haukaas, and L.A. Akslen A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer Clin Cancer Res 13 2007 7003 7011
27. R. Umbas, J.A. Schalken, T.W. Aalders, B.S. Carter, H.F. Karthaus, H.E. Schaafsma, F.M. Debruyne, and W.B. Isaacs Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer Cancer Res 52 1992 5104 5109
28. J. Pontes Jr, M. Srougi, P.M. Borra, M.F. Dall' Oglio, L.A. Ribeirão-Filho, and K.R. Leite E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer Appl Immunohistochem Mol Morphol 18 2010 179 184
29. M.A. Rubin, N.R. Mucci, J. Figurski, A. Fecko, K.J. Pienta, and M.L. Day E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology Hum Pathol 32 2001 690 697
30. B. Saha, A. Arase, S.S. Imam, D. Tsao-Wei, W.Y. Naritoku, S. Groshen, L.W. Jones, and S.A. Imam Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone Prostate 68 2008 78 84
31. D.S. Darling, R.P. Stearman, Y. Qi, M.S. Qiu, and J.P. Feller Expression of Zfhep/deltaEF1 protein in palate, neural progenitors, and differentiated neurons Gene Expr Patterns 3 2003 709 717
32. K.R. Shaw, C.N. Wrobel, and J.S. Brugge Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis J Mammary Gland Biol Neoplasia 9 2004 297 310
33. G.A. Gmyrek, M. Walburg, C.P. Webb, M. Yu H-, X. You, E.D. Vaughan, G.F. Vande Woude, and B.S. Knudsen Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor Am J Pathol 159 2001 579 590
34. M.P. Roudier, L.D. True, C.S. Higano, H. Vesselle, W. Ellis, P. Lange, and R.L. Vessella Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone Hum Pathol 34 2003 646 653
35. A.Y. Liu, E. Corey, F. Bladou, P.H. Lange, and R.L. Vessella Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration Int J Cancer 65 1996 85 89
36. E. Corey, J.E. Quinn, F. Bladou, L.G. Brown, M.P. Roudier, J.M. Brown, K.R. Buhler, and R.L. Vessella Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells Prostate 52 2002 20 33
37. G. Berx, and F. van Roy Involvement of members of the cadherin superfamily in cancer Cold Spring Harb Perspect Biol 1 2009 a003129
38. A. Sharma, W.S. Yeow, A. Ertel, I. Coleman, N. Clegg, C. Thangavel, C. Morrissey, X. Zhang, C.E. Comstock, A.K. Witkiewicz, L. Gomella, E.S. Knudsen, P.S. Nelson, and K.E. Knudsen The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression J Clin Invest 120 2010 4478 4492
39. T. Tsukamoto, and S.K. Nigam Cell-cell dissociation upon epithelial cell scattering requires a step mediated by the proteosome J Biol Chem 274 1999 24579 24584
40. J. Chunthapong, E.A. Seftor, Z. Khalkhali-Ellis, R.E. Seftor, S. Amir, D.M. Lubaroff, P.M. Heidger Jr, and M.J. Hendrix Dual roles of E-cadherin in prostate cancer invasion J Cell Biochem 91 2004 649 661
41. C.F. Gao, Q. Xie, Y.L. Su, J. Koeman, S.K. Khoo, M. Gustafson, B.S. Knudsen, R. Hay, N. Shinomiya, and G.F. Vande Woude Proliferation and invasion: plasticity in tumor cells Proc Natl Acad Sci USA 102 2005 10528 10533
42. P.D. Bos, X.H. Zhang, C. Nadal, W. Shu, R.R. Gomis, D.X. Nguyen, A.J. Minn, M.J. van de Vijver, W.L. Gerald, J.A. Foekens, and J. Massague Genes that mediate breast cancer metastasis to the brain Nature 459 2009 1005 1009
43. C.C. Yates, C.R. Shepard, D.B. Stolz, and A. Wells Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin Br J Cancer 96 2007 1246 1252
44. Y.L. Chao, C.R. Shepard, and A. Wells Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition Mol Cancer 9 2010 179
45. C.L. Chaffer, J.P. Brennan, J.L. Slavin, T. Blick, E.W. Thompson, and E.D. Williams Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2 Cancer Res 66 2006 11271 11278
46. G. Browne, A.E. Sayan, and E. Tulchinsky ZEB proteins link cell motility with cell cycle control and cell survival in cancer Cell Cycle 9 2010 886 891
47. M. Guarino Src signaling in cancer invasion J Cell Physiol 223 2010 14 26
48. M.E. Costantino, R.P. Stearman, G.E. Smith, and D.S. Darling Cell-specific phosphorylation of Zfhep transcription factor Biochem Biophys Res Commun 296 2002 368 373
49. L. Larue, C. Antos, S. Butz, O. Huber, V. Delmas, M. Dominis, and R. Kemler A role for cadherins in tissue formation Development 122 1996 3185 3194
50. Y. Wang, N. Mah, A. Prigione, K. Wolfrum, M.A. Andrade-Navarro, and J. Adjaye A transcriptional roadmap to the induction of pluripotency in somatic cells Stem Cell Rev 6 2010 282 296
51. K. Pfannkuche, H. Summer, O. Li, J. Hescheler, and P. Droge The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells? Stem Cell Rev 5 2009 224 230
52. C.H. Glover, M. Marin, C.J. Eaves, C.D. Helgason, J.M. Piret, and J. Bryan Meta-analysis of differentiating mouse embryonic stem cell gene expression kinetics reveals early change of a small gene set PLoS Comput Biol 2 2006 e158
53. R.M. Hoffman The pluripotency of hair follicle stem cells Cell Cycle 5 2006 232 233
54. C.E. Hirst, E.S. Ng, L. Azzola, A.K. Voss, T. Thomas, E.G. Stanley, and A.G. Elefanty Transcriptional profiling of mouse and human ES cells identifies SLAIN1, a novel stem cell gene Dev Biol 293 2006 90 103
55. L. Bai, and L.R. Rohrschneider s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue Genes Dev 24 2010 1882 1892
56. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schuler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, and T. Brabletz The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 2009 1487 1495
57. G. van der Pluijm Epithelial plasticity, cancer stem cells and bone metastasis formation Bone 48 2010 37 43
58. X.H. Zhang, Q. Wang, W. Gerald, C.A. Hudis, L. Norton, M. Smid, J.A. Foekens, and J. Massague Latent bone metastasis in breast cancer tied to Src-dependent survival signals Cancer Cell 16 2009 67 78
59. A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
60. O. Schmidt-Kittler, T. Ragg, A. Daskalakis, M. Granzow, A. Ahr, T.J. Blankenstein, M. Kaufmann, J. Diebold, H. Arnholdt, P. Muller, J. Bischoff, D. Harich, G. Schlimok, G. Riethmuller, R. Eils, and C.A. Klein From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci USA 100 2003 7737 7742